Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8333 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8313 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8288 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8253 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8243 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD1613 |
Approved |
0.821 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD37 |
Approved |
0.8086 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8086 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8086 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8084 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8027 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7973 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7882 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7881 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.787 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7844 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7836 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7806 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7805 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7798 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7758 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7744 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7711 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7644 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7616 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7597 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7595 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7595 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD7240 |
Approved |
0.758 |
Intermediate Similarity |
NPD5762 |
Approved |
0.758 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7547 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7543 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7543 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6190 |
Approved |
0.75 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7484 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7484 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.747 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7455 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7451 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.744 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7368 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7326 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.732 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7296 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7285 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7278 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7258 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7256 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD919 |
Approved |
0.723 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7226 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7207 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7207 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7205 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7197 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7195 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7193 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7182 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7171 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7126 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7126 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7117 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7105 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7081 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7076 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7076 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7067 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7055 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7012 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7 |
Intermediate Similarity |
NPD5089 |
Approved |
0.6994 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6993 |
Remote Similarity |
NPD1608 |
Approved |
0.6989 |
Remote Similarity |
NPD5242 |
Approved |
0.6986 |
Remote Similarity |
NPD228 |
Approved |
0.6982 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6982 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD1240 |
Approved |
0.6975 |
Remote Similarity |
NPD6032 |
Approved |
0.697 |
Remote Similarity |
NPD2677 |
Approved |
0.6954 |
Remote Similarity |
NPD5709 |
Phase 3 |
0.6948 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6946 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD7843 |
Approved |
0.6937 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6937 |
Remote Similarity |
NPD5735 |
Approved |
0.6933 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6933
|
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |